Late stage investors in The Netherlands
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | •••@lspvc.com | +31 20••• |
| EXOR N.V. | Private equity firm | Amsterdam, The Netherlands | •••@exor.com | 39-11-••• |
| Gilde Healthcare | Private equity firm | Utrecht, The Netherlands | •••@gildehealthcare.com | 617-39••• |
| Maven 11 Capital | Venture capital firm | Amsterdam, The Netherlands | •••@maven11.com | |
| Invest-NL | Venture capital firm | Amsterdam, The Netherlands | •••@invest-nl.nl | +31 (0••• |
| InnovationQuarter | Venture capital firm | The Hague, The Netherlands | •••@innovationquarter.nl | +31 6 ••• |
| Prosus | Private equity firm | Amsterdam, The Netherlands | •••@naspers.com | +31 23••• |
| Newion | Venture capital firm | Amsterdam, The Netherlands | •••@newion.com | +31 20••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 85 of the 127 late stage investors in The Netherlands have a published email address, 61 a phone number and 117 a website.
- EQT Life Sciences has the most recorded investments, 198, 74 of them as lead investor.
- 15 of them are investors in at least one company that closed its most recent round in the last 12 months.
- M Ventures is an investor in 5 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is East Africa Fruits' $26.0M Series B on 7 October 2026.
- Software is the most common sector across their 439 portfolio companies (67%).
- Early stage venture is the most common investment stage, recorded for 99 of them (78%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Late stage investors in The Netherlands
30 of 127, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | Health care, Biotech | FoRx Therapeutics | 1 | 198 | 74 | 55 | •••@lspvc.com | +31 20••• | In the CSV |
| 2 | M Ventures | Corporate venture arm, Venture capital firm | Amsterdam, The Netherlands | Health care, Biotech | Polaris Electro-Optics, Quintessent, Future Fertility | 5 | 171 | 64 | 17 | In the CSV | ||
| 3 | EXOR N.V. | Private equity firm | Amsterdam, The Netherlands | Artificial intelligence, Health care | Lupa Pets, Bee | 163 | 33 | 21 | •••@exor.com | 39-11-••• | In the CSV | |
| 4 | Prosus Ventures | Corporate venture arm | Amsterdam, The Netherlands | Artificial intelligence, Fintech | Ema, Constantinople, Equal AI | 4 | 159 | 79 | 14 | +31 20••• | In the CSV | |
| 5 | Shell Ventures | Corporate venture arm | Rijswijk, The Netherlands | Energy, Artificial intelligence | i6 Group, Corvus Energy, Bumper | 158 | 55 | 28 | ||||
| 6 | Gilde Healthcare | Private equity firm, Venture capital firm | Utrecht, The Netherlands | Health care, Biotech | ADCendo | 1 | 127 | 47 | 43 | •••@gildehealthcare.com | 617-39••• | In the CSV |
| 7 | ING Group | Investment bank | Amsterdam, The Netherlands | Fintech, Hardware | Nearfield Instruments, HQLAx, WeLab | 3 | 124 | 28 | 45 | 31 20 ••• | In the CSV | |
| 8 | Maven 11 Capital | Venture capital firm | Amsterdam, The Netherlands | Fintech, Artificial intelligence | Plural Energy, Bagel Labs, Sophon | 116 | 26 | 5 | •••@maven11.com | In the CSV | ||
| 9 | Invest-NL | Venture capital firm, Venture debt fund | Amsterdam, The Netherlands | Health care, Hardware | Vitestro | 1 | 98 | 36 | 8 | •••@invest-nl.nl | +31 (0••• | In the CSV |
| 10 | InnovationQuarter | Venture capital firm | The Hague, The Netherlands | Biotech, Health care | Pan Cancer T | 1 | 85 | 17 | 12 | •••@innovationquarter.nl | +31 6 ••• | In the CSV |
| 11 | Prosus | Private equity firm, Venture capital firm | Amsterdam, The Netherlands | 83 | 53 | 21 | •••@naspers.com | +31 23••• | In the CSV | |||
| 12 | Newion | Venture capital firm | Amsterdam, The Netherlands | Artificial intelligence, Commerce | Dexter Energy Services, Churned, Neople | 81 | 44 | 15 | •••@newion.com | +31 20••• | In the CSV | |
| 13 | Innovation Industries | Venture capital firm | Amsterdam, The Netherlands | Hardware, Energy | VitalFluid | 1 | 75 | 36 | 5 | •••@innovationindustries.com | In the CSV | |
| 14 | Finch Capital | Venture capital firm | Amsterdam, The Netherlands | Fintech, Cybersecurity | AccountsIQ, eflow, Fourthline | 74 | 40 | 16 | •••@finchcapital.com | +31 20••• | In the CSV | |
| 15 | TIN Capital | Venture capital firm | Amsterdam, The Netherlands | 67 | 46 | 18 | •••@tincapital.vc | +31 30••• | In the CSV | |||
| 16 | SET Ventures | Venture capital firm | Amsterdam, The Netherlands | Energy, Artificial intelligence | Tibo Energy, Instagrid, Green Eagle Solutions | 66 | 27 | 11 | •••@setventures.com | +31 20••• | In the CSV | |
| 17 | Holland Capital | Private equity firm, Venture capital firm | Amsterdam, The Netherlands | Health care | Channext, Relay42, Karify | 65 | 46 | 20 | •••@hollandventure.com | +31020••• | In the CSV | |
| 18 | Prime Ventures | Venture capital firm | Amsterdam, The Netherlands | Commerce, Fintech | Vitesse, Orderchamp, ZeroLight | 65 | 32 | 21 | •••@primeventures.com | +31 20••• | In the CSV | |
| 19 | ABN AMRO Fund | Corporate venture arm, Investment bank | Amsterdam, The Netherlands | Health care, Biotech | Envision, Xention, Pieris | 62 | 17 | 22 | •••@nl.abanmro.com | (010) ••• | In the CSV | |
| 20 | henQ | Venture capital firm | Amsterdam, The Netherlands | Commerce, Hardware | Kanpla, Modash.io, imagino | 59 | 37 | 12 | •••@henq.vc | In the CSV | ||
| 21 | FORWARD.one | Venture capital firm | Amstelveen, The Netherlands | Hardware, Artificial intelligence | AlixLabs | 1 | 57 | 29 | 4 | •••@forward.one | In the CSV | |
| 22 | Anterra Capital | Venture capital firm | Amsterdam, The Netherlands | Biotech, Commerce | La Fourche, Enko Chem, Inc., Smartwyre | 57 | 22 | 4 | •••@anterracapital.com | 716 22••• | In the CSV | |
| 23 | Endeit Capital | Venture capital firm | Amsterdam, The Netherlands | Hardware, Fintech | Infraspeak, Sastrify, IPRally | 52 | 35 | 28 | •••@endeit.com | +31 20••• | In the CSV | |
| 24 | TRGC | Hedge fund, Venture capital firm | Amsterdam, The Netherlands | Fintech | Sumi Network, Onramper | 52 | 1 | 0 | •••@trgc.io | In the CSV | ||
| 25 | Keen Venture Partners | Venture capital firm | Amsterdam, The Netherlands | Fintech, Artificial intelligence | allO | 1 | 51 | 27 | 7 | •••@keenventurepartners.com | +31 (0••• | In the CSV |
| 26 | ING Ventures | Corporate venture arm | Amsterdam, The Netherlands | Artificial intelligence, Fintech | Stemly AI, fintonic, qodek | 49 | 16 | 10 | •••@ing.com | |||
| 27 | DOEN Participaties | Venture capital firm | Amsterdam, The Netherlands | Energy, Artificial intelligence | MX3D, Orbisk, Oorja Development Solutions | 49 | 7 | 3 | •••@doen.nl | 020 - ••• | In the CSV | |
| 28 | NLC | Startup accelerator, Startup incubator | Amsterdam, The Netherlands | Health care, Artificial intelligence | Ansana, SERDA therapeutics, MindAffect | 44 | 33 | 0 | •••@nlc.health | +31(0)••• | In the CSV | |
| 29 | DOB Equity | Private equity firm, Venture capital firm | Veessen, The Netherlands | Education, Fintech | Moringa School, Laboremus Uganda | 43 | 24 | 0 | •••@gmail.com | +31 57••• | In the CSV | |
| 30 | Aqua Spark | Private equity firm, Venture capital firm | Utrecht, The Netherlands | Biotech, Health care | Kuehnle Agrosystems | 1 | 41 | 22 | 2 | •••@aqua-spark.nl | +31 (0••• | In the CSV |
Table 1. Late stage investors in The Netherlands: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 127.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | M Ventures | Amsterdam, The Netherlands | 5 | 19 | Polaris Electro-Optics, Quintessent, Future Fertility |
| 2 | Prosus Ventures | Amsterdam, The Netherlands | 4 | 27 | Ema, Constantinople, Equal AI |
| 3 | ING Group | Amsterdam, The Netherlands | 3 | 6 | Nearfield Instruments, HQLAx, WeLab |
| 4 | Goodwell Investments | Amsterdam, The Netherlands | 1 | 5 | East Africa Fruits |
| 5 | Rabo Ventures | Amsterdam, The Netherlands | 1 | 3 | Arkea Bio |
| 6 | Chemelot Ventures | Urmond, The Netherlands | 1 | 2 | Matisse Pharmaceuticals |
| 7 | Innovation Industries | Amsterdam, The Netherlands | 1 | 6 | VitalFluid |
| 8 | Movendo Capital | Amsterdam, The Netherlands | 1 | 1 | Petfolk |
| 9 | Aqua Spark | Utrecht, The Netherlands | 1 | 6 | Kuehnle Agrosystems |
| 10 | Keen Venture Partners | Amsterdam, The Netherlands | 1 | 12 | allO |
| 11 | Gilde Healthcare | Utrecht, The Netherlands | 1 | 9 | ADCendo |
| 12 | Invest-NL | Amsterdam, The Netherlands | 1 | 10 | Vitestro |
| 13 | EQT Life Sciences | Amsterdam, The Netherlands | 1 | 23 | FoRx Therapeutics |
| 14 | InnovationQuarter | The Hague, The Netherlands | 1 | 11 | Pan Cancer T |
| 15 | FORWARD.one | Amstelveen, The Netherlands | 1 | 4 | AlixLabs |
Table 2. Late stage investors in The Netherlands: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| East Africa Fruits | East Africa Fruits distributes fresh fruits from local farms to B2B buyers. | Commerce | Dar Es Salaam, Tanzania | Series B | $26.0M | 2026-10-07 | $47.0M | Goodwell Investments | 101 to 250 | 2013 |
| Arkea Bio | Arkea Bio develops technology that reduces greenhouse gas emissions from agriculture. | Biotech | Charlestown, United States | Series A | $15.0M | 2026-09-29 | $60.5M | Rabo Ventures | 11 to 50 | 2021 |
| Ema | Ema builds AI agents that automate enterprise workflows. | Artificial intelligence | San Francisco, United States | Series B | $77.0M | 2026-09-23 | $138.0M | Prosus Ventures | 51 to 100 | 2023 |
| Matisse Pharmaceuticals | Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. | Biotech | Geleen, The Netherlands | Series A | $16.0M | 2026-09-17 | $22.0M | Chemelot Ventures | 11 to 50 | 2014 |
| Polaris Electro-Optics | Polaris Electro-Optics develops integrated photonics for communications and computation. | Hardware | Broomfield, United States | Series B | $50.0M | 2026-09-15 | $63.2M | M Ventures | 11 to 50 | 2021 |
| Quintessent | Quintessent commercializes quantum dot-based lasers and photonic integrated circuits. | Artificial intelligence | Goleta, United States | Series A | $40.0M | 2026-08-24 | $53.9M | M Ventures | 11 to 50 | 2019 |
| Constantinople | Constantinople provides software-as-a-service banking platform solutions for retail and business customers. | Artificial intelligence | Sydney, Australia | Series B | $44.4M | 2026-08-18 | $98.2M | Prosus Ventures | 101 to 250 | 2022 |
| Petfolk | Petfolk provides in-person and virtual veterinary care for pets. | Health care | Charlotte, United States | Series D | $40.0M | 2026-08-13 | $156.0M | Movendo Capital | 101 to 250 | 2020 |
| Kuehnle Agrosystems | Kuehnle Agrosystems develops plant-based systems to produce biologically active compounds through biotech research. | Biotech | Honolulu, United States | Series B | $3.0M | 2026-07-06 | $11.8M | Aqua Spark | 1 to 10 | 2007 |
| Nearfield Instruments | Nearfield Instruments develops and supplies metrology and inspection equipment for semiconductor manufacturing process control. | Hardware | Rotterdam, The Netherlands | Series D | $380.0M | 2026-06-22 | $597.8M | ING Group | 251 to 500 | 2016 |
Table 3. Late stage investors in The Netherlands: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 296 | 67% |
| Artificial intelligence | 90 | 21% |
| Fintech | 76 | 17% |
| Health care | 73 | 17% |
| Hardware | 69 | 16% |
| Commerce | 51 | 12% |
| Biotech | 51 | 12% |
| Cybersecurity | 27 | 6% |
| Energy | 25 | 6% |
| Education | 17 | 4% |
Table 4. Late stage investors in The Netherlands: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Late stage investors | 127 | 100% |
| Early stage investors | 99 | 78% |
| Seed investors | 65 | 51% |
| Venture investors | 50 | 39% |
| Private equity investors | 32 | 25% |
| Convertible note investors | 13 | 10% |
| Debt investors | 8 | 6% |
| Post IPO investors | 8 | 6% |
Table 5. Late stage investors in The Netherlands by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Investors | Share |
|---|---|---|
| Amsterdam | 72 | 57% |
| Utrecht | 8 | 6% |
| Rotterdam | 5 | 4% |
| The Hague | 3 | 2% |
| Maassluis | 3 | 2% |
| Eindhoven | 3 | 2% |
| Amstelveen | 2 | 2% |
| Bussum | 2 | 2% |
| Maastricht | 2 | 2% |
| Blaricum | 2 | 2% |
| 's-hertogenbosch | 2 | 2% |
| Rijswijk | 1 | 1% |
Table 6. Late stage investors in The Netherlands by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 13 | 12% |
| 2010s | 40 | 38% |
| 2000s | 23 | 22% |
| 1990s | 20 | 19% |
| 1980s | 5 | 5% |
| 1970s | 1 | 1% |
Table 7. Late stage investors in The Netherlands by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include late stage investors and its headquarters is in The Netherlands. On 16 November 2026 that is 127 investors.
- 85 rows carry an email address and 61 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 127 rows: 10 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many late stage investors in The Netherlands are on the list?
- 127, in the file dated 16 November 2026. 15 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 85 of the 127 carry an email address in the download and 61 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 127 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 127 rows, 85 firm email addresses and 61 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 57 of the 85 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.